NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

Minoxidil的全球市場

Minoxidil: Global Markets

出版商 BCC Research 商品編碼 1010207
出版日期 內容資訊 英文 58 Pages
訂單完成後即時交付
價格
Minoxidil的全球市場 Minoxidil: Global Markets
出版日期: 2021年06月09日內容資訊: 英文 58 Pages
簡介

全球Minoxidil的市場規模,預計從2020年到2025年以4.3%的年複合成長率成長,從2020年的19億美元,到2025年達到24億美元。各地區中,北美市場預計從2020年的9億9,810萬美元,成長到2025年的12億美元,從2020年到2025年的年複合成長率成為4.5%。歐洲市場,預計從2020年的5億3,120萬美元成長到2025年的6億3,510萬美元,從2020年到2025年的年複合成長率記錄3.6%。

本報告提供全球Minoxidil市場調查,市場概要,各市場區隔(類型、給藥途徑、用途)、各地區的市場規模的變化與預測,市場成長的推動要素及阻礙因素分析,市場機會,市場趨勢,產品平台,法規、專利,競爭情形,主要企業簡介等彙整資訊。

目錄

第1章 簡介

第2章 概要、亮點

  • 全球市場規模

第3章 市場概要

  • 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會

第4章 法規、專利情勢

  • 法規情形
  • 美國
  • 歐洲
  • 亞太地區
  • 專利概要

第5章 市場趨勢

  • 產品平台
  • 未來的潛在的治療方法
  • 策略與開發

第6章 新型冠狀病毒感染疾病(COVID-19)對市場的影響

  • 概要
  • COVID-19危機
  • 對製藥產業的短期影響
  • 長期性的影響
  • 供應鏈的影響
  • COVID-19對Minoxidil市場的影響
  • 目前預測

第7章 全球Minoxidil市場:各類型

  • 含2% Minoxidil
  • 含5% Minoxidil
  • 含10% Minoxidil

第8章 全球Minoxidil市場:各給藥途徑

  • 局部給藥
  • 口服給藥

第9章 全球Minoxidil市場:各用途

  • 脫髮症
  • 其他慢性疾病

第10章 全球Minoxidil市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 澳洲
    • 韓國
    • 其他
  • 其他地區

第11章 企業簡介

  • APOTEX INC.
  • CIPLA
  • DR. REDDY'S LABORATORIES LTD.
  • JOHNSON & JOHNSON
  • MYLAN(VIATRIS)
  • NOVARTIS AG
  • PERRIGO COMPANY PLC
  • PFIZER INC.
  • TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

第12章 附錄

目錄
Product Code: PHM253A

Highlights:

The global market for minoxidil should grow from $1.9 billion in 2020 to $2.4 billion by 2025 with a compound annual growth rate (CAGR) of 4.3% for the period of 2020-2025.

North American minoxidil market should grow from $998.1 million in 2020 to $1.2 billion by 2025 with a compound annual growth rate (CAGR) of 4.5% for the period of 2020-2025.

European minoxidil market should grow from $531.2 million in 2020 to $635.1 million by 2025 with a compound annual growth rate (CAGR) of 3.6% for the period of 2020-2025.

Report Scope

The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the competitive landscape. Regulatory scenarios, drivers, restraints, and opportunities

are covered.

For this report, the market is segmented based on type, form, application and geography or region. Based on type, the market in this report is segmented into 5%, 2% and 10% Minoxidil. The forms of Minoxidil are topical and oral. In terms of applications, the report covers alopecia and chronic diseases.

In terms of regional analysis, the market is segmented into North America, Europe, Asia-Pacific, and ROW, with detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, and India. For market estimates, data are provided for 2019 as the base year, with estimates for 2020 and forecast values for 2025.

Report Includes

  • 11 data tables and 24 additional tables
  • An overview of the global market for minoxidil
  • Estimation of the market size and analyses of market trends, with data from 2018, 2019, 2020, and projection of CAGR through 2025
  • Market share analysis of minoxidil by type, form, application, and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
  • Coverage of ongoing scientific discoveries and technological advances and insights into marketed and pipeline (R&D) products, product recalls, and reimbursement policies
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players, including Dr. Reddy's Laboratories, Cipla, Johnson & Johnson, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Global Market Size

Chapter 3 Market Overview

  • Market Dynamics
  • Drivers
  • Market Restraints
  • Market Opportunities

Chapter 4 Regulatory and Patent Landscape

  • Regulatory Landscape
  • U.S.
  • Europe
  • Asia-Pacific
  • Patent Reviews

Chapter 5 Market Trends

  • Product Pipeline
  • Future Potential Treatments
  • Strategies and Developments

Chapter 6 Impact of COVID-19 on Market

  • Overview
  • COVID-19 Crisis
  • Short-Term Impact on Pharmaceutical Industry
  • Long-Term Impact
  • Impact on Supply Chain
  • Impact of COVID-19 on the Market for Minoxidil
  • Current Outlook

Chapter 7 Market Breakdown by Type

  • 2% Minoxidil
  • 5% Minoxidil
  • 10% Minoxidil

Chapter 8 Market Breakdown by Form

  • Topical
  • Oral Minoxidil

Chapter 9 Market Breakdown by Application

  • Alopecia
  • Other Chronic Diseases

Chapter 10 Market Breakdown by Region

  • Overview
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • India
  • China
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 11 Company Profiles

  • APOTEX INC.
  • CIPLA
  • DR. REDDY'S LABORATORIES LTD.
  • JOHNSON & JOHNSON
  • MYLAN (VIATRIS)
  • NOVARTIS AG
  • PERRIGO COMPANY PLC
  • PFIZER INC.
  • TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter 12 Appendix: Acronyms Used in this Report

List of Tables

  • Summary Table : Global Market for Minoxidil, by Region, Through 2025
  • Table 1 : Global Elderly (60+) Population Growth, 1980-2020
  • Table 2 : Drug Alternatives for Alopecia
  • Table 3 : Natural Alternatives for Alopecia
  • Table 4 : Patents Issued for Minoxidil
  • Table 5 : U.S. Patents Issued for Hair Loss Treatment
  • Table 6 : Minoxidil Pipeline
  • Table 7 : Potential Treatment Options for Types of Alopecia
  • Table 8 : Breakthrough Therapy Designation, 2018-2020
  • Table 9 : Global Market for 2% Minoxidil Solution, by Region, Through 2025
  • Table 10 : Global Market for 5% Minoxidil Solution, by Region, Through 2025
  • Table 11 : Global Market for 10% Minoxidil Solution, by Region, Through 2025
  • Table 12 : Global Market for Topical Minoxidil, by Region, Through 2025
  • Table 13 : Global Market for Oral Minoxidil, by Region, Through 2025
  • Table 14 : Classification of Alopecia
  • Table 15 : Global Market for Minoxidil in the Treatment of Alopecia, by Region, Through 2025
  • Table 16 : Global Market for Minoxidil in the Treatment of Other Chronic Diseases, by Region, Through 2025
  • Table 17 : North American Market for Minoxidil, by Country, Through 2025
  • Table 18 : European Market for Minoxidil, by Country, Through 2025
  • Table 19 : Asia-Pacific Market for Minoxidil, by Country, Through 2025
  • Table 20 : Apotex: Minoxidil Product Portfolio
  • Table 21 : Cipla: Minoxidil Product Portfolio
  • Table 22 : Dr. Reddy's Laboratories: Minoxidil Product Portfolio
  • Table 23 : Dr. Reddy's Laboratories: Key Developments, 2018
  • Table 24 : Johnson & Johnson: Minoxidil Product Portfolio
  • Table 25 : Johnson & Johnson: Key Developments, 2018
  • Table 26 : Mylan: Minoxidil Product Portfolio.
  • Table 27 : Sandoz: Minoxidil Product Portfolio
  • Table 28 : Perrigo Company Plc: Minoxidil Product Portfolio
  • Table 29 : Perrigo Company Plc: Key Developments, 2018
  • Table 30 : Pfizer: Minoxidil Product Portfolio
  • Table 31 : Taisho Pharmaceutical: Minoxidil Products
  • Table 32 : Teva Pharmaceutical: Minoxidil Products
  • Table 33 : Teva Pharmaceutical: Key Developments
  • Table 34 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market for Minoxidil, by Type, 2019-2025
  • Figure 1 : Trends in Global Elderly (60+ Years) Population Growth, 1990-2100
  • Figure 2 : Impact of COVID-19 on Pharmaceutical Industry
  • Figure 3 : Global Market for 2% Minoxidil Solution, 2019-2025
  • Figure 4 : Global Market for 5% Minoxidil Solution, 2019-2025
  • Figure 5 : Global Market for 10% Minoxidil Solution, 2019-2025
  • Figure 6 : Global Market for Topical Minoxidil, 2019-2025
  • Figure 7 : Global Market for Oral Minoxidil, 2019-2025
  • Figure 8 : Global Market for Minoxidil in the Treatment of Alopecia, 2019-2025
  • Figure 9 : Global Market for Minoxidil in the Treatment of Other Chronic Diseases, 2019-2025
  • Figure 10 : Global Market for Minoxidil, by Region, 2019-2025
  • Figure 11 : Global Market Shares for Minoxidil, by Region, 2019
  • Figure 12 : North American Market for Minoxidil, 2019-2025
  • Figure 13 : European Market for Minoxidil, 2019-2025
  • Figure 14 : Asia-Pacific Market for Minoxidil, 2019-2025
  • Figure 15 : Rest of World Market for Minoxidil, 2019-2025